Free tool
Rare disease stocks
We cover 268 companies grouped under the Rare disease theme. The median market value in the group is $441.93M. Across the group, the median move over the past trading day is +1.20%. 56% of the 252 with a 200-day average trade above it. Price change over the past year runs from −69.6% to +210.8% across the middle 80 percent of the group, with a median of +18.8%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Daily Analysis
Aug 26, 2026Generated from today's data · Not investment adviceThe group contains 268 companies. The company in the middle by market value is worth $441.9 million, and its one-day move is 1.2%. Among 252 companies measured, 56.0% trade above their own 200-day average, which is a stock's average price over its past 200 trading days.
Results over the past year vary widely across all 268 companies measured: the company in the middle is up 18.8%, while roughly one in ten is down at least 69.6% and roughly one in ten is up more than 210.8%. Among the listed largest members, one Vertex Pharmaceuticals Incorporated listing is down 83.2%, while Roivant Sciences Ltd. is up 213.3%.
The standout companies by size band were Arrowhead Pharmaceuticals, Inc. (ARWR) and Alnylam Pharmaceuticals, Inc. (0HD2.L) among large caps; Oruka Therapeutics, Inc. (ORKA) and BioMarin Pharmaceutical Inc. (0HNC.L) among mid caps; Q32 Bio Inc. (QTTB) and InflaRx N.V. (IFRX) among small caps; and SCYNEXIS, Inc. (SCYX) and Tenax Therapeutics, Inc. (TENX) among micro caps.
Table
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| VX1.DE | Vertex Pharmaceuticals Incorporated | $140.77B | Large cap | +40.14% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | $140.14B | Large cap | −83.17% |
| VRTX | Vertex Pharmaceuticals Incorporated | $140.04B | Large cap | +42.14% |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $112.52B | Large cap | +42.39% |
| ARGX | argenx SE | $63.78B | Large cap | +50.52% |
| A1RG34.SA | argenx SE | $63.17B | Large cap | +44.49% |
| 0HD2.L | Alnylam Pharmaceuticals, Inc. | $35.05B | Large cap | −46.85% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −45.88% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | $31.87B | Large cap | −11.75% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | $31.78B | Large cap | −49.89% |
| INSM | Insmed Incorporated | $27.07B | Large cap | −3.45% |
| ROIV | Roivant Sciences Ltd. | $26.26B | Large cap | +213.32% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +108.87% |
| ASND | Ascendis Pharma A/S | $16.59B | Large cap | +32.89% |
| BBIO | BridgeBio Pharma, Inc. | $15.85B | Large cap | +70.01% |
| CORT | Corcept Therapeutics Incorporated | $13.36B | Large cap | +79.56% |
| 0JAV.L | Insmed Incorporated | $12.89B | Large cap | −6.25% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.80B | Large cap | +13.03% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.60B | Large cap | +2.09% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | $12.54B | Large cap | +6.36% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +329.16% |
| CYTK | Cytokinetics, Incorporated | $10.77B | Large cap | +109.29% |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +52.01% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +202.82% |
| ABVX.PA | ABIVAX Société Anonyme | $10.42B | Large cap | +42.59% |
| 0JDI.L | Ionis Pharmaceuticals, Inc. | $10.40B | Large cap | +49.07% |
| PTGX | Protagonist Therapeutics, Inc. | $10.01B | Large cap | +164.75% |
| 0HNC.L | BioMarin Pharmaceutical Inc. | $9.93B | Mid cap | +12.68% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +182.02% |
| IMVT | Immunovant, Inc. | $8.95B | Mid cap | +192.14% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +3.09% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +14.26% |
| SRRK | Scholar Rock Holding Corporation | $7.09B | Mid cap | +74.77% |
| 0HI3.L | Arrowhead Pharmaceuticals, Inc. | $6.98B | Mid cap | +317.86% |
| ORKA | Oruka Therapeutics, Inc. | $6.74B | Mid cap | +601.72% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +168.53% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.17B | Mid cap | +142.74% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $6.13B | Mid cap | +49.03% |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +378.90% |
| TVTX | Travere Therapeutics, Inc. | $6.06B | Mid cap | +288.91% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +36.58% |
| GRFS | Grifols, S.A. | $5.44B | Mid cap | −17.62% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +102.62% |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +209.16% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.17B | Mid cap | +340.71% |
| MANE | Veradermics, Incorporated | $4.11B | Mid cap | +171.13% |
| CAMX.ST | Camurus AB (publ) | $3.87B | Mid cap | −14.52% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +52.72% |
| CLDX | Celldex Therapeutics, Inc. | $3.24B | Mid cap | +87.96% |
| IRON | Disc Medicine, Inc. | $3.16B | Mid cap | +38.71% |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +58.44% |
| 0RD1.L | Camurus AB (publ) | $2.84B | Mid cap | −13.50% |
| VRDN | Viridian Therapeutics, Inc. | $2.74B | Mid cap | +30.21% |
| PHVS | Pharvaris N.V. | $2.62B | Mid cap | +57.76% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −9.60% |
| TRVI | Trevi Therapeutics, Inc. | $2.56B | Mid cap | +146.57% |
| VERA | Vera Therapeutics, Inc. | $2.54B | Mid cap | +65.32% |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +176.20% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +17.16% |
| MLYS | Mineralys Therapeutics, Inc. | $2.32B | Mid cap | +78.70% |
| 009420.KS | Hanall Biopharma Co., Ltd. | $2.32B | Mid cap | +108.57% |
| COAG | Hemab Therapeutics Holdings, Inc. | $2.32B | Mid cap | +46.03% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.23B | Mid cap | +38.03% |
| ZBIO | Zenas BioPharma, Inc. | $2.20B | Mid cap | +103.93% |
| STOK | Stoke Therapeutics, Inc. | $2.16B | Mid cap | +77.32% |
| ADMA | ADMA Biologics, Inc. | $2.14B | Mid cap | −42.86% |
| PVLA | Palvella Therapeutics, Inc. | $2.14B | Mid cap | +195.71% |
| NEU.AX | Neuren Pharmaceuticals Limited | $2.08B | Mid cap | +18.47% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $1.95B | Small cap | −9.02% |
| SEPN | Septerna, Inc. | $1.93B | Small cap | +245.32% |
| ETON | Eton Pharmaceuticals, Inc. | $1.80B | Small cap | +268.93% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.74B | Small cap | −16.24% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +335.60% |
| AVLN | Avalyn Pharma Inc. | $1.69B | Small cap | +29.54% |
| 0L35.L | Sarepta Therapeutics, Inc. | $1.69B | Small cap | +4.63% |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +128.55% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +580.25% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.61B | Small cap | +137.42% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.59B | Small cap | +12.48% |
| TYRA | Tyra Biosciences, Inc. | $1.59B | Small cap | +122.42% |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.53B | Small cap | +18.84% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | $1.51B | Small cap | +301.52% |
| PYC.AX | PYC Therapeutics Limited | $1.48B | Small cap | +63.71% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +107.85% |
| 0LIF.L | Ultragenyx Pharmaceutical Inc. | $1.40B | Small cap | −11.63% |
| OMER | Omeros Corporation | $1.40B | Small cap | +343.22% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +176.46% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.52% |
| 0HB0.L | Agios Pharmaceuticals, Inc. | $1.19B | Small cap | −14.25% |
| SVRA | Savara Inc. | $1.15B | Small cap | +78.34% |
| 006280.KS | GC Biopharma Corp. | $1.06B | Small cap | −1.88% |
| AVTX | Avalo Therapeutics, Inc. | $1.06B | Small cap | +110.00% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −47.18% |
| CLYM | Climb Bio Inc | $1.02B | Small cap | +619.35% |
| DSGN | Design Therapeutics, Inc. | $981.28M | Small cap | +201.54% |
| ANNX | Annexon, Inc. | $976.33M | Small cap | +139.53% |
| DBVT | DBV Technologies S.A. | $940.80M | Small cap | +52.91% |
| DBV.PA | DBV Technologies S.A. | $928.30M | Small cap | +54.11% |
| SLN | Silence Therapeutics plc | $849.65M | Small cap | +170.16% |
| GNFT.PA | Genfit S.A. | $836.50M | Small cap | +293.99% |
| PHAR | Pharming Group N.V. | $833.06M | Small cap | −19.75% |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +710.87% |
| 0QNA.L | Basilea Pharmaceutica AG | $762.45M | Small cap | +38.97% |
| TECX | Tectonic Therapeutic, Inc. | $737.21M | Small cap | +53.48% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $725.40M | Small cap | +245.67% |
| ASMB | Assembly Biosciences, Inc. | $718.32M | Small cap | +32.72% |
| ZVRA | Zevra Therapeutics, Inc. | $714.98M | Small cap | +28.63% |
| AGMB | AgomAb Therapeutics NV | $690.46M | Small cap | −4.30% |
| GYRE | Gyre Therapeutics, Inc. | $682.86M | Small cap | −18.54% |
| CRMD | CorMedix Inc. | $667.20M | Small cap | −37.65% |
| AYJ.DE | Valneva SE | $659.69M | Small cap | −25.10% |
| VALN | Valneva SE | $642.90M | Small cap | −28.10% |
| ZURA | Zura Bio Limited | $605.64M | Small cap | +208.29% |
| AQST | Aquestive Therapeutics, Inc. | $602.46M | Small cap | +31.61% |
| 0KBU.L | Omeros Corporation | $575.28M | Small cap | +341.05% |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −57.66% |
| 005257.KS | GC Corp. | $553.81M | Small cap | −41.91% |
| KMDA | Kamada Ltd. Ordinary Shares | $497.90M | Small cap | +26.12% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $490.26M | Small cap | +41.87% |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | $487.17M | Small cap | +41.67% |
| QTTB | Q32 Bio Inc. | $485.84M | Small cap | +728.43% |
| RZLT | Rezolute, Inc. | $482.42M | Small cap | −28.43% |
| AVIR | Atea Pharmaceuticals, Inc. | $441.93M | Small cap | +48.36% |
| LRMR | Larimar Therapeutics, Inc. | $432.15M | Small cap | +11.83% |
| XFOR | X4 Pharmaceuticals, Inc. | $412.45M | Small cap | +4.79% |
| ENTA | Enanta Pharmaceuticals, Inc. | $410.67M | Small cap | +62.59% |
| 4552.T | JCR Pharmaceuticals Co., Ltd. | $397.97M | Small cap | −7.40% |
| UPB | Upstream Bio, Inc. | $393.26M | Small cap | −57.08% |
| CUV.AX | Clinuvel Pharmaceuticals Limited | $381.21M | Small cap | −21.84% |
| IKT | Inhibikase Therapeutics, Inc. | $348.84M | Small cap | +42.05% |
| PRQR | ProQR Therapeutics N.V. | $335.86M | Small cap | +5.78% |
| IFRX | InflaRx N.V. | $302.10M | Small cap | +167.10% |
| TRDA | Entrada Therapeutics, Inc. | $296.70M | Small cap | +35.35% |
| TTRX | Turn Therapeutics Inc. | $295.48M | Small cap | +39.00% |
| FULC | Fulcrum Therapeutics, Inc. | $294.51M | Small cap | −39.78% |
| SION | Sionna Therapeutics, Inc. | $282.58M | Small cap | −74.02% |
| ELDN | Eledon Pharmaceuticals, Inc. | $281.98M | Small cap | +35.02% |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | $279.25M | Small cap | +185.26% |
| IVVD | Invivyd, Inc. | $277.81M | Small cap | +67.62% |
| 0OB3.L | Valneva SE | $270.41M | Small cap | −24.84% |
| AKBA | Akebia Therapeutics, Inc. | $265.58M | Small cap | −68.37% |
| SLGL | Sol-Gel Technologies Ltd. | $265.20M | Small cap | +289.14% |
| XUP.DE | Genfit S.A. | $258.22M | Small cap | +166.82% |
| 0QN1.L | Santhera Pharmaceuticals Holding AG | $254.58M | Small cap | +12.30% |
| 0T6G.L | Q32 Bio Inc. | $246.69M | Small cap | — |
| RNA | Prosensa Holding B.V. Ordinary Shares | $239.48M | Small cap | −5.08% |
| PEPG | PepGen Inc. | $237.21M | Small cap | +161.45% |
| CRDL | Cardiol Therapeutics Inc. | $233.65M | Small cap | +75.44% |
| CRDL.TO | Cardiol Therapeutics Inc. | $233.07M | Small cap | +72.50% |
| KROS | Keros Therapeutics, Inc. | $213.74M | Small cap | −20.87% |
| ANTX | AN2 Therapeutics, Inc. | $213.59M | Small cap | +403.11% |
| SIGA | SIGA Technologies, Inc. | $211.24M | Small cap | −60.50% |
| ARMP | Armata Pharmaceuticals, Inc. | $206.73M | Small cap | +113.85% |
| MSLE | Satellos Bioscience Inc. | $200.92M | Small cap | +82.17% |
| MSCL.TO | Satellos Bioscience Inc. | $199.37M | Small cap | +80.56% |
| PLX | Protalix BioTherapeutics, Inc. | $193.37M | Small cap | +50.62% |
| 0AB6.L | Hyloris Pharmaceuticals SA | $185.32M | Small cap | −32.01% |
| SPRB | Spruce Biosciences, Inc. | $182.21M | Small cap | +697.48% |
| MDWD | MediWound Ltd. | $167.45M | Small cap | −24.81% |
| AARD | Aardvark Therapeutics, Inc. | $158.67M | Small cap | −19.80% |
| CRNO-B.ST | Cereno Scientific AB (publ) | $155.36M | Small cap | −53.95% |
| UNCY | Unicycive Therapeutics, Inc. | $146.28M | Small cap | +27.51% |
| MIST | Milestone Pharmaceuticals Inc. | $144.42M | Small cap | −31.36% |
| 4599.T | StemRIM | $140.21M | Small cap | +15.91% |
| EQ | Equillium, Inc. | $139.50M | Small cap | +14.74% |
| DXB.AX | Dimerix Limited | $131.21M | Small cap | −35.79% |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +166.87% |
| INO | Inovio Pharmaceuticals, Inc. | $129.25M | Small cap | −33.85% |
| 0H8T.L | Aclaris Therapeutics, Inc. | $122.82M | Small cap | +265.21% |
| MDP.TO | Medexus Pharmaceuticals Inc. | $116.99M | Small cap | +80.70% |
| RFL | Rafael Holdings, Inc. | $113.88M | Small cap | +52.38% |
| PTHS | Pelthos Therapeutics Inc. | $104.13M | Small cap | +20.41% |
| PYPD | PolyPid Ltd. | $101.25M | Small cap | +47.83% |
| GOSS | Gossamer Bio, Inc. | $99.97M | Micro cap | −91.33% |
| ILA.AX | Island Pharmaceuticals Limited | $99.59M | Micro cap | +104.35% |
| ABNX.PA | ABIONYX Pharma SA | $97.56M | Micro cap | −16.20% |
| PAR.AX | Paradigm Biopharmaceuticals Limited | $96.60M | Micro cap | −22.41% |
| 0RAG.L | ABIONYX Pharma SA | $95.77M | Micro cap | −18.26% |
| FBIO | Fortress Biotech, Inc. | $94.38M | Micro cap | +23.58% |
| PLYX | Polaryx Therapeutics, Inc. | $94.21M | Micro cap | −94.66% |
| RLYB | Rallybio Corporation | $89.67M | Micro cap | +262.65% |
| TENX | Tenax Therapeutics, Inc. | $86.82M | Micro cap | −60.81% |
| TELO | Telomir Pharmaceuticals, Inc. | $81.15M | Micro cap | −19.18% |
| RCE.AX | Recce Pharmaceuticals Ltd | $81.01M | Micro cap | −12.79% |
| FBIOP | Fortress Biotech, Inc. | $71.45M | Micro cap | +141.55% |
| STX.L | Shield Therapeutics plc | $70.81M | Micro cap | −41.98% |
| SPRO | Spero Therapeutics, Inc. | $70.76M | Micro cap | −33.51% |
| ALTHX.PA | THX Pharma Société Anonyme | $70.40M | Micro cap | +89.35% |
| RNTX | Rein Therapeutics Inc. | $69.01M | Micro cap | −32.20% |
| IMA | ImageneBio, Inc. | $63.80M | Micro cap | −60.78% |
| 0IIM.L | Esperion Therapeutics, Inc. | $61.56M | Micro cap | +46.64% |
| ATYR | aTyr Pharma, Inc. | $55.91M | Micro cap | −88.95% |
| SCYX | SCYNEXIS, Inc. | $51.64M | Micro cap | +514.20% |
| NSRX | Nasus Pharma Ltd. | $48.01M | Micro cap | −48.69% |
| MCRB | Seres Therapeutics, Inc. | $46.81M | Micro cap | −74.00% |
| GRCE | Grace Therapeutics, Inc. | $46.28M | Micro cap | −32.31% |
| MREO | Mereo BioPharma Group plc | $44.97M | Micro cap | −83.82% |
| EDSA | Edesa Biotech, Inc. | $42.90M | Micro cap | +83.88% |
| BOT.AX | Botanix Pharmaceuticals Limited | $39.22M | Micro cap | −87.10% |
| QNCX | Quince Therapeutics, Inc. | $34.05M | Micro cap | +95.76% |
| NNVC | NanoViricides, Inc. | $32.93M | Micro cap | −12.84% |
| 520A.T | J-PHARMACEUTICALS CO LTD | $31.08M | Micro cap | −60.71% |
| ALDVI.PA | Advicenne S.A. | $29.99M | Micro cap | +41.44% |
| 4591.T | Ribomic Inc. | $29.85M | Micro cap | −22.94% |
| IMM.L | ImmuPharma plc | $29.03M | Micro cap | +83.56% |
| 0RQJ.L | Saniona AB (publ) | $27.98M | Micro cap | −13.86% |
| BRNS | Barinthus Biotherapeutics plc | $26.96M | Micro cap | −44.77% |
| JSPR | Jasper Therapeutics, Inc. | $23.96M | Micro cap | −75.67% |
| TVRD | Tvardi Therapeutics, Inc. | $23.74M | Micro cap | −93.77% |
| RVX.TO | Resverlogix Corp. | $23.62M | Micro cap | +5.00% |
| 4884.T | Kringle Pharma, Inc. | $22.99M | Micro cap | −7.41% |
| COCP | Cocrystal Pharma, Inc. | $21.77M | Micro cap | −26.62% |
| VYNE | VYNE Therapeutics Inc | $19.07M | Micro cap | +8687.69% |
| KTTA | Pasithea Therapeutics Corp. | $18.71M | Micro cap | −21.90% |
| CALC | CalciMedica, Inc. | $17.10M | Micro cap | −78.92% |
| CMMB | Chemomab Therapeutics Ltd. | $16.85M | Micro cap | −33.91% |
| 4881.T | FunPep Company Limited | $15.92M | Micro cap | −56.14% |
| HIND | Vyome Holdings, Inc. | $15.65M | Micro cap | −80.23% |
| ALBPS.PA | Biophytis S.A. | $12.86M | Micro cap | −53.47% |
| ANNX.ST | Annexin Pharmaceuticals AB (publ) | $10.31M | Micro cap | −49.23% |
| QNRX | Quoin Pharmaceuticals, Ltd. | $10.18M | Micro cap | −31.02% |
| AZTR | Azitra, Inc. | $9.55M | Micro cap | −78.97% |
| PHR.WA | Pharmena S.A. | $9.49M | Micro cap | −7.51% |
| IMRN | Immuron Limited | $9.20M | Micro cap | −36.84% |
| SNGX | Soligenix, Inc. | $8.81M | Micro cap | −87.06% |
| IMC.AX | Immuron Limited | $8.33M | Micro cap | −46.38% |
| XCUR | Exicure, Inc. | $7.79M | Micro cap | −79.90% |
| INM | InMed Pharmaceuticals Inc. | $7.69M | Micro cap | −35.43% |
| VBS.AX | Vectus Biosystems Limited | $6.65M | Micro cap | +87.50% |
| PULM | Pulmatrix, Inc. | $5.84M | Micro cap | −67.81% |
| BIOSGN.ST | Biosergen AB (publ) | $5.62M | Micro cap | −95.33% |
| JAGX | Jaguar Health, Inc. | $4.78M | Micro cap | −98.52% |
| CVKD | Cadrenal Therapeutics, Inc. | $4.74M | Micro cap | −87.58% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.48M | Micro cap | +205.34% |
| GRI | GRI Bio, Inc. | $4.28M | Micro cap | −95.14% |
| XRTX | XORTX Therapeutics Inc. | $4.11M | Micro cap | −44.74% |
| BIT.AX | Biotron Limited | $3.99M | Micro cap | −33.33% |
| SXTP | 60 Degrees Pharmaceuticals, Inc. | $3.97M | Micro cap | −78.10% |
| MTNB | Matinas BioPharma Holdings, Inc. | $2.90M | Micro cap | −90.82% |
| ANR.AX | Anatara Lifesciences Ltd | $2.04M | Micro cap | +12.50% |
| APTA.ST | Aptahem AB (publ) | $1.53M | Micro cap | −72.50% |
| APLI.TO | Appili Therapeutics Inc. | $1.44M | Micro cap | −25.00% |
| VBIO | Valion Bio, Inc. | $660.05K | Micro cap | −95.00% |
| 0R55.L | BioSenic S.A. | $26.40K | Micro cap | −23.08% |
| ALNEV.PA | Neovacs S.A. | $29.00 | Micro cap | −11.54% |
| 0A43.L | Inovio Pharmaceuticals, Inc. | — | — | −45.78% |
| 0A4D.L | Equillium, Inc. | — | — | +24.24% |
| 0A6I.L | Soligenix, Inc. | — | — | −86.94% |
| 0A8E.L | Xeris Biopharma Holdings, Inc. | — | — | +10.09% |
| 0A8U.L | Synlogic, Inc. | — | — | −15.17% |
| 0A9G.L | Mereo BioPharma Group plc | — | — | −83.87% |
| 0ABW.L | Egetis Therapeutics AB (publ) | — | — | +49.12% |
| 0D1W.L | Biophytis S.A. | — | — | −53.43% |
| 0JQ2.L | KALA BIO, Inc. | — | — | −99.82% |
| 0K1R.L | Viridian Therapeutics, Inc. | — | — | +31.82% |
| 0L49.L | SCYNEXIS, Inc. | — | — | +543.07% |
| 0QNS.L | CURATIS AG CURATIS AG AG ORD SH | — | — | −15.04% |
| 0UNL.L | NEKTAR THERAPEUTICS NEKTAR THER | — | — | +14.54% |
| 1AE.DE | argenx SE | — | — | +35.39% |
| 2X1.DE | ABIVAX Société Anonyme | — | — | +35.69% |
| BIOV.SW | BioVersys AG | — | — | −8.49% |
| BPBS.PA | BIOPHYTIS BSA | — | — | 0.00% |
| BSLN.SW | Basilea Pharmaceutica AG | — | — | +38.40% |
| CESSA.CO | Cessatech A/S | — | — | −46.63% |
| CURN.SW | Curatis Holding AG | — | — | +73.80% |
| DBV.DE | DBV Technologies S.A. | — | — | +61.15% |
| PHGN.DE | Pharming Group N.V. | — | — | −21.41% |
| SANN.SW | Santhera Pharmaceuticals Holding AG | — | — | +15.63% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.